In vitro activity of silver sulfadiazine against Herpesvirus hominis.
Silver sulfadiazine, at a concentration of 10 mug/ml, inhibits Herpesvirus hominis types 1 and 2 in vitro. The antiviral effect is directly related to concentration of the drug and duration of exposure.
D000650:Amnion / Q000166:cytology; D000818:Animals; D002417:Cattle; D002460:Cell Line; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008826:Microbial Sensitivity Tests; D011817:Rabbits / Q000276:immunology; D012834:Silver / Q000494:pharmacology* / Q000633:toxicity; D012835:Silver Nitrate / Q000494:pharmacology; D018139:Simplexvirus / Q000187:drug effects*; D013411:Sulfadiazine / Q000494:pharmacology* / Q000633:toxicity; D013997:Time Factors
D013411:Sulfadiazine; D012834:Silver; D012835:Silver Nitrate